These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8874149)

  • 21. Role of endogenous endothelin in chronic heart failure: effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling.
    Mulder P; Richard V; Derumeaux G; Hogie M; Henry JP; Lallemand F; Compagnon P; Macé B; Comoy E; Letac B; Thuillez C
    Circulation; 1997 Sep; 96(6):1976-82. PubMed ID: 9323089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of endothelin in the maintenance of blood pressure in conscious rats with chronic heart failure. Acute effects of the endothelin receptor antagonist Ro 47-0203 (bosentan).
    Teerlink JR; Löffler BM; Hess P; Maire JP; Clozel M; Clozel JP
    Circulation; 1994 Nov; 90(5):2510-8. PubMed ID: 7955209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endothelin receptor inhibition with bosentan delays onset of liver injury in streptozotocin-induced diabetic condition.
    Demirci E; Ferah I; Gundogdu C; Ozkanlar S; Baygutalp NK; Bayir Y; Calik M; Ayaz G
    Drug Res (Stuttg); 2015 May; 65(5):272-80. PubMed ID: 24918345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protection against aspirin-induced human gastric mucosal injury by bosentan, a new endothelin-1 receptor antagonist.
    Duggan AE; Stack W; Hull M; Filipowicz B; Knifton A; Crome R; Weber C; Bishop A; Polak J; Hawkey CJ
    Aliment Pharmacol Ther; 1999 May; 13(5):631-5. PubMed ID: 10233186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antihypertensive effect of an endothelin receptor antagonist in DOCA-salt spontaneously hypertensive rats.
    Schiffrin EL; Sventek P; Li JS; Turgeon A; Reudelhuber T
    Br J Pharmacol; 1995 Aug; 115(8):1377-81. PubMed ID: 8564194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endothelin-1 does not mediate the endothelium-dependent hypoxic contractions of small pulmonary arteries in rats.
    Lazor R; Feihl F; Waeber B; Kucera P; Perret C
    Chest; 1996 Jul; 110(1):189-97. PubMed ID: 8681627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endothelin B receptor-mediated vasoconstriction induced by endothelin A receptor antagonist.
    Zhang Y; Oliver JR; Horowitz JD
    Cardiovasc Res; 1998 Sep; 39(3):665-73. PubMed ID: 9861310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of the ETA/ETB receptor antagonist, bosentan on endothelin-1-induced myocardial ischaemia and oedema in the rat.
    Filep JG; Fournier A; Földes-Filep E
    Br J Pharmacol; 1995 Sep; 116(2):1745-50. PubMed ID: 8528554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beneficial effect of ursodeoxycholic acid on mucosal damage in trinitrobenzene sulphonic acid-induced colitis.
    Kullmann F; Arndt H; Gross V; Rüschoff J; Schölmerich J
    Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1205-11. PubMed ID: 9471027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of the paracrine liver endothelin system in the pathogenesis of CCl4-induced liver injury.
    Hocher B; Zart R; Diekmann F; Slowinski T; Thöne-Reineke C; Lutz J; Bauer C
    Eur J Pharmacol; 1995 Dec; 293(4):361-8. PubMed ID: 8748689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bosentan, a mixed endothelin receptor antagonist, inhibits superoxide anion-induced pain and inflammation in mice.
    Serafim KG; Navarro SA; Zarpelon AC; Pinho-Ribeiro FA; Fattori V; Cunha TM; Alves-Filho JC; Cunha FQ; Casagrande R; Verri WA
    Naunyn Schmiedebergs Arch Pharmacol; 2015 Nov; 388(11):1211-21. PubMed ID: 26246053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paracrine renal endothelin system in rats with liver cirrhosis.
    Hocher B; Zart R; Diekmann F; Rohmeiss P; Distler A; Neumayer HH; Bauer C; Gross P
    Br J Pharmacol; 1996 May; 118(2):220-7. PubMed ID: 8735618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An orally active inhibitor of leukotriene synthesis accelerates healing in a rat model of colitis.
    Wallace JL; Keenan CM
    Am J Physiol; 1990 Apr; 258(4 Pt 1):G527-34. PubMed ID: 1970708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improvement of vascular endothelial function using the oral endothelin receptor antagonist bosentan in patients with systemic sclerosis.
    Sfikakis PP; Papamichael C; Stamatelopoulos KS; Tousoulis D; Fragiadaki KG; Katsichti P; Stefanadis C; Mavrikakis M
    Arthritis Rheum; 2007 Jun; 56(6):1985-93. PubMed ID: 17530638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of endothelin receptor antagonism with bosentan on peripheral nerve function in experimental diabetes.
    Stevens EJ; Tomlinson DR
    Br J Pharmacol; 1995 May; 115(2):373-9. PubMed ID: 7670740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of bosentan, a new potent endothelin receptor antagonist, on the pathogenesis of cerebral vasospasm.
    Shigeno T; Clozel M; Sakai S; Saito A; Goto K
    Neurosurgery; 1995 Jul; 37(1):87-90; discussion 90-1. PubMed ID: 8587696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective effect of Et-1 receptor antagonist bosentan on paracetamol induced acute liver toxicity in rats.
    Yayla M; Halici Z; Unal B; Bayir Y; Akpinar E; Gocer F
    Eur J Pharmacol; 2014 Mar; 726():87-95. PubMed ID: 24462570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The ocular endothelin system: a novel target for the treatment of endotoxin-induced uveitis with bosentan.
    Keles S; Halici Z; Atmaca HT; Yayla M; Yildirim K; Ekinci M; Akpinar E; Altuner D; Cakici O; Bayraktutan Z
    Invest Ophthalmol Vis Sci; 2014 May; 55(6):3517-24. PubMed ID: 24833743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects on feline pial arterioles in situ of bosentan, a non-peptide endothelin receptor antagonist.
    Patel TR; McAuley MA; McCulloch J
    Eur J Pharmacol; 1994 Jul; 260(1):65-71. PubMed ID: 7794420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibiotic treatment with ampicillin accelerates the healing of colonic damage impaired by aspirin and coxib in the experimental colitis. Importance of intestinal bacteria, colonic microcirculation and proinflammatory cytokines.
    Zwolinska-Wcislo M; Krzysiek-Maczka G; Ptak-Belowska A; Karczewska E; Pajdo R; Sliwowski Z; Urbanczyk K; Drozdowicz D; Konturek SJ; Pawlik WW; Brzozowski T
    J Physiol Pharmacol; 2011 Jun; 62(3):357-68. PubMed ID: 21893697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.